Autologous Stem Cell Transplantation for Crohn's Disease
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of administering
high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem
cells (PBSC) in pediatric and adult patients with severe Crohn's disease.